By identifying BBB dysfunction, HARM offers an alternative pathway to predict stroke recurrence, particularly in embolic stroke mechanisms, and may enhance risk stratification beyond ABCD2 and DWI. This evidence concerns the gene ABCD2 and stroke disorder.